Evidence map›Paper›PMID 37064143›Full record

ArticleFrontiers in oncology2023

Cancer patient and provider responses to companion scales assessing experiences with LGBTQI-affirming healthcare.

Mandi L Pratt-Chapman, Yan Wang, Gwendolyn P Quinn, Sylvia Shirima, Sarah Adler, Ruta Brazinskaite, Charles Kamen, Asa Radix, Barbara Warren, Kristen Eckstrand and 1 more

Abstract read
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mandi L Pratt-ChapmanDepartment of Medicine, The George Washington University School of Medicine and Health Sciences, Washington, DC, United States.
Yan WangThe George Washington University Cancer Center, Washington, DC, United States.
Gwendolyn P QuinnDepartments of OB-GYN and Population Health, Grossman School of Medicine, Perlmutter Cancer Center, New York University, New York, NY, United States.
Sylvia ShirimaThe George Washington University Cancer Center, Washington, DC, United States.
Sarah AdlerThe George Washington University Cancer Center, Washington, DC, United States.
Ruta BrazinskaiteThe George Washington University Cancer Center, Washington, DC, United States.
Charles KamenDepartment of Surgery and Wilmot Cancer Institute, University of Rochester, Rochester, NY, United States.
Asa RadixCallen-Lorde Community Health Center, New York, NY, United States.
Barbara WarrenMount Sinai Health System and School of Medicine, New York, NY, United States.
Kristen EckstrandDepartment of Psychiatry, University of Pittsburgh, Pittsburg, PA, United States.
Ana Maria LopezSidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, United States.

Funding

Evaluating Companion Diagnostics to the anal Pap test to improve prediction of AIN2+ in HIV-infected MSMR01CA203604 · NCI · GEORGE WASHINGTON UNIVERSITY · PI JORDAN, JEANNE ANN · 2017 to 2021
$2.0M
NCI NIH HHS R01 CA203604
6 · The paper itself

Abstract

Background: Sexual and gender minority (SGM) persons are at a higher risk for some cancers and may have poorer health outcomes as a result of ongoing minority stress, social stigma, and cisnormative, heteronormative healthcare environments. This study compared patient and provider experiences of affirming environmental and behavioral cues and also examined provider-reported knowledge, attitudes, behaviors, and clinical preparedness in caring for SGM patients among a convenience sample. Methods: National convenience samples of oncology providers ( Results: Both patient and provider samples were predominantly female sex assigned at birth, cisgender, and heterosexual. Providers were more likely than patients to report affirming cues in clinic, as well as the ability for patients to easily document their name in use and pronouns. Providers were more likely to report asking about patient values and preferences of care versus patients' recollection of being asked. Patients were more likely to report understanding why they were asked about both sex assigned at birth and gender identity compared to providers' perceptions that patients would understand being asked about both. Patients were also more likely to report comfort with providers asking about sex assigned at birth and gender identity compared to providers' perceptions of patient comfort. SGM providers had greater knowledge of SGM patient social determinants of health and cancer risks; felt more prepared to care for gay patients; were more likely to endorse the importance of knowing patient sexual orientation and gender identity; and were more likely to indicate a responsibility to learn about SGM patient needs and champion positive system changes for SGM patients compared to heterosexual/cisgender peers. Overall, providers wished for more SGM-specific training. Conclusion: Differences between patient and provider reports of affirming environments as well as differences between SGM and heterosexual/cisgender provider care support the need for expanded professional training specific to SGM cancer care.

Indexed as

affirming carecultural competenceLGBTQImeasurementpatient experienceprovider experience

Identifiers

PMID37064143
PMCPMC10103145

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.